Eyeblink classical conditioning to auditory and olfactory stimuli: Performance among older adults with and without the apolipoprotein E ε4 allele

Neuropsychology

Volumn 19, Issue 4, 2005, Pages 437-445

  Moore, Anna Bacon ^a,b,g   Salmon, David P ^b,e   Bondi, Mark W ^b,c,d   Murphy, Claire ^a,b,f  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAN DIEGO STATE UNIVERSITY   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Learning; Memory; Olfaction

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUDITORY STIMULATION; CLINICAL ARTICLE; CONDITIONED REFLEX; CONDITIONING; CONTROLLED STUDY; DISEASE COURSE; EYELID REFLEX; FEMALE; GENETIC RISK; HETEROZYGOTE; HUMAN; LEARNING; MALE; MEMORY; PRIORITY JOURNAL; SMELLING;

ACOUSTIC STIMULATION; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BLINKING; CONDITIONING, CLASSICAL; FEMALE; HUMANS; MALE; ODORS; OLFACTORY PATHWAYS; REACTION TIME; SENSORY THRESHOLDS;

EID: 23044513853     PISSN: 08944105     EISSN: None     Source Type: Journal    
DOI: 10.1037/0894-4105.19.4.437     Document Type: Article

References (98)

1. Arriagada, P. V., Marzolff, K., & Hyman, B. T. (1992). Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology, 42, 1681-1688.
2. Averback, P. (1983). Two new lesions in Alzheimer's disease. Lancet, ii, 1203.
3. Bacon, A. W., Bondi, M. W., Salmon, D. P., & Murphy, C. (1998). Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Annals of the New York Academy of Sciences, 855, 723-731.
4. Berger, T. W. (1984, May, 11). Long-term potentiation of hippocampal synaptic transmission affects rate of behavioral learning. Science, 224, 627-630.
5. Berger, T. W., Alger, B., & Thompson, R. F. (1976, April, 30). Neuronal substrate of classical conditioning in the hippocampus. Science, 192, 483-485.
6. Berger, T. W., Berry, S. D., & Thompson, R. F. (1986). Role of the hippocampus in classical conditioning of aversive and appetitive behaviors. In R. L. Isaacson & K. H. Pribram (Eds.), The hippocampus (pp. 203-239). New York: Plenum Press.
7. Berger, T. W., & Thompson, R. F. (1978). Identification of pyramidal cells as the critical elements in hippocampal neuronal plasticity during learning. Proceedings of the National Academy of Sciences, USA, 75, 1572-1576.
8. Berger, T. W., & Thompson, R. F. (1982). Hippocampal cellular plasticity during extinction of classically conditioned nictitating membrane behavior. Behavioral Brain Research, 4, 63-76.
9. Bondi, M. W., Monsch, A. U., Galasko, D., Butters, N., Salmon, D. P., & Delis, D. C. (1994). Preclinical cognitive markers of dementia of the Alzheimer type. Neuropsychology, 8, 374-384.
10. Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thai, L. J. (1999). Neuropsychological function and Apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychology and Aging, 14, 195-303.
11. Bondi, M. W., Salmon, D. P., Monsch, A. U., Galasko, D., Butters, N., Klauber, M. R., et al. (1995). Episodic memory changes are associated with the APOE ε4 allele in nondemented older adults. Neurology, 45, 2203-2206.
12. Braak, H., & Braak, E. (1997a). Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiology of Aging, 54(Suppl. 4), S85-S88.
13. Braak, H., & Braak, E. (1997b). Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiology of Aging, 18, 351-357.
14. Braak, H., & Braak, E. (1998). Evolution of neuronal changes in the course of Alzheimer's disease. Journal of Neural Transmission, supplementum, 351-357.
15. Cain, W. S. (1989). Testing olfaction. American Journal of Otolaryngology, 4, 252-256.
16. Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2001). Patterns of cognitive decline in presymptomatic Alzheimer disease: A prospective community study. Archives of General Psychiatry, 58, 853-858.
17. Christian, K. M., & Thompson, R. F. (2003). Neural substrates of eyeblink conditioning: Acquisition and retention. Learning and Memory, 10, 427-455.
18. Collie, A., & Maruff, P. (2000). The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neuroscience and Biobehavioral Reviews, 24, 365-374.
19. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993, August 13). Gene dose of apolipoprotein type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 26, 921-923.
20. Corwin, J., Serby, M., & Rotrosen, J. (1986). Olfactory deficits in AD: What we know about the nose. Neurobiology of Aging, 7, 580-582.
21. Doty, R. L., Reyes, P. F., & Gregor, T. P. (1987). Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Research Bulletin, 18, 597-600.
22. Duff, K., McCaffrey, R. J., & Solomon, G. S. (2002). The Pocket Smell Test: Successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. Journal of Neuropsychiatry and Clinical Neuroscience, 14, 197-201.
23. Esiri, M. M., & Wilcock, G. K. (1984). The olfactory bulbs in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 47, 56-60.
24. Geroldi, C., Laakso, M. P., DeCarli, C., Beltramello, A., Bianchetti, A., Soininen, H., et al. (2000). Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: A volumetric MRI study. Journal of Neurology, Neurosurgery, and Psychiatry, 68, 93-96.
25. Ghebremedhim, E., Schultz, C., Braak, E., & Braak, H. (1998). High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Experimental Neurology, 153, 152-155.
26. Gilbert, P. E., & Murphy, C. (2004a). Differences between recognition memory and remote memory for olfactory and visual stimuli in nondemented elderly individuals genetically at risk for Alzheimer's disease. Experimental Gerontology, 39, 433-441.
27. Gilbert, P. E., & Murphy, C. (2004b). The effect of the ApoE ε4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease and healthy elderly controls. Journal of Clinical and Experimental Neuropsychology, 6, 779-794.
28. Gomez-Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., et al. (1996). Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Annals of Neurology, 39, 62-70.
29. Gormezano, I. (1966). Classical conditioning. In J. B. Sidowski (Ed.), Experimental methods and instrumentation in psychology (pp. 385-420). New York: McGraw-Hill.
30. Graves, A. B., Bowen, J. D., Rajaram, L., McCormick, W. C., McCurry, S. M., Schellenberg, G. D., & Larson, E. B. (1999). Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E ε4 status. Neurology, 53, 1480-1487.
31. Gray, A. J., Staples, V., Murren, K., Dhariwal, A., & Bentham, P. (2001). Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry, 16, 513-517.
32. Hixson, J., & Vernier, D. (1991). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhA1. Journal of Lipid Research, 31, 545-548.
33. Huff, F. J., Boller, F., Lucchelli, F., Querriera, R., Beyer, J., & Belle, S. (1987). The neurologic examination in patients with probable Alzheimer's disease. Archives of Neurology, 44, 929-932.
34. Hyman, B. T., & Mann, D. M. A. (1991). Neurofibrillary pathology in Down's syndrome individuals of various ages. In K. Iqbal, D. R. C. McLachlan, B. Winbald, & H. M. Wisniewski (Eds.), Alzheimer's disease: Basic mechanisms, diagnosis and therapeutic strategies (pp. 105-113). New York: Wiley.
35. Kesslack, J. P., Cotman, C. W., Chui, H. C., Van Den Noort, S., Fang, H., Pfeffer, R., & Lynch, G. (1988). Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease. Neurobiology of Aging, 9, 399-403.
36. Knupfer, L., & Spiegel, R. (1986). Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. International Journal of Geriatric Psychiatry, 1, 3-14.
37. Koss, E., Weiffenbach, J. M., Haxby, J. V., & Friedland, R. P. (1988). Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology, 38, 1228-1232.
38. Lange, K. L., Bondi, M. W., Galasko, D. G., Delis, D. C., Salmon, D. P., & Thal, L. J. (2002). Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype. Journal of the International Neuropsychological Society, 8, 943-955.
39. Mattis, S. (1988). Dementia Rating Scale: Professional manual. Odessa, FL: Psychological Assessment Resources.
40. Moore, A. B., & Murphy, C. (1998). The effect of short versus long interstimulus interval on human eyeblink classical conditioning to an olfactory stimulus. Society for Neuroscience Abstracts, 24 (Pt. 1), 163.
41. Moore, A. B., & Murphy, C. (1999). A demonstration of classical conditioning of the human eyeblink to an olfactory stimulus. Physiology and Behavior, 66, 689-693.
42. Morgan, C. D., & Murphy, C. (2002). Olfactory event-related potentials in Alzheimer's disease. Journal of the International Neuropsychological Society, 8, 753-763.
43. Morgan, C. D., Nordin, S., & Murphy, C. (1995). Odor identification as an early marker for Alzheimer's disease: Impact of lexical functioning and detection sensitivity. Journal of Clinical and Experimental Psychology, 17, 793-803.
44. Murphy, C. (1987). Olfactory psychophysics. In T. E. Finger & W. L. Silver (Eds.), Neurobiology of taste and smell (pp. 251-274). New York: Wiley.
45. Murphy, C., Bacon, A. W., Bondi, M. W., & Salmon, D. P. (1998). Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Annals of the New York Academy of Sciences, 855, 744-750.
46. Murphy, C., Gilmore, M. M., Seery, C. S., Salmon, D. P., & Lasker, B. R. (1990). Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiology of Aging, 11, 465-469.
47. Murphy, C., Jernigan, T. L., & Fennema-Notestine, C. (2003). Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: A structural MRI study. Journal of the International Neuropsychological Society, 9, 459-471.
48. Murphy, C., Lasker, B. R., & Salmon, D. P. (1987). Olfactory dysfunction and odor memory in Alzheimer's disease, Huntington's disease and normal aging [Abstract]. Neuroscience, 13, 1403.
49. Murphy, C., Nordin, S., de Wijk, R. A., Cain, W. S., & Polich, J. (1994). Olfactory-evoked potentials: Assessment of young and elderly, and comparison to psychophysical threshold. Chemical Senses, 19, 47-56.
50. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Research, 541, 163-166.
51. Nordin, S., & Murphy, C. (1996). Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. Neuropsychology, 10, 112-119.
52. Nordin, S., & Murphy, C. (1998). Odor memory in normal aging and Alzheimer's disease. Annals of the New York Academy of Sciences, 855, 686-693.
53. Ohm, T. G., & Braak, H. (1987). Olfactory bulb changes in Alzheimer's disease. Acta Neuropathologica, 73, 365-369.
54. Ohm, T. G., Kirca, M., Bohl, J., Scharnagl, H., Gross, W., & Marz, W. (1995). Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience, 66, 583-587.
55. Papka, M., & Woodruff-Pak, D. S. (1996). Number of trials needed to assess human eyeblink classical conditioning. Psychology and Aging, 11, 373-376.
56. Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P., & Gauthier, S. (1993). Apolipoprotein E polymorphism and Alzheimer's disease. Lancet, 342, 697-699.
57. Price, J. L. (1993). The relationship between tangle and plaque formation during healthy aging and mild dementia. Neurobiology of Aging, 14, 661-663.
58. Price, J. L. (1997). Diagnostic criteria for Alzheimer's disease. Neurobiology of Aging, 18, S67-S70.
59. Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991). The distribution of tangles, plaques, and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiology of Aging, 12, 295-312.
60. Price, J. L., Davis, P., & Robbins, L. (1987). Mapping of tangles and Alz-50 immunoreactive cells in aged human brains with and without Alzheimer's dementia [Abstract]. Society for Neuroscience, 13, 1461.
61. Reed, T., Carmelli, D., Swan, G. E., Breitner, J. C. S., Welsh, K. A., Jarvik, G. P., Deeb, S., & Auwerx, J. (1994). Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Archives of Neurology, 51, 1189-1192.
62. Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., et al. (1996). Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. The New England Journal of Medicine, 334, 752-758.
63. Reyes, P. F., Golden, G. T., Fariello, R. G., Fagel, L., & Zalewska, M. (1985). Olfactory pathways in Alzheimer's disease (AD): Neuropathological studies [Abstract]. Society for Neurosciences, 11, 168.
64. Riemenschneider, M., Schmolke, M., Lautenschlager, N., Vanderstichele, H., Vanmechelen, E., Guder, W. G., & Kurz, A. (2002). Association of CSF apolipoprotein E, Aβ42 and cognition in Alzheimer's disease. Neurobiology of Aging, 23, 205-211.
65. Royet, J. P., Croisile, B., Williamson-Vasta, R., Hibert, O., Serclerat, D., & Guerin, J. (2001). Rating of different olfactory judgements in Alzheimer's disease. Chemical Senses, 26, 409-417.
66. Saunders, A. M., Schmader, K., Breitner, J. C. S., Benson, M. D., Brown, W. T., Goldfarb, L., et al. (1993). Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. The Lancet, 342, 710-711.
67. Schiffman, S. S., Clark, C. M., & Warwick, Z. S. (1990). Gustatory and olfactory dysfunction in dementia: Not specific to Alzheimer's disease. Neurobiology of Aging, 11, 597-600.
68. Schiffman, S. S., Graham, B. G., Sattely-Miller, E. A., Zervakis, J., & Welsh-Bohmer, K. (2002). Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease. Neurobiology of Aging, 23, 397-404.
69. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., et al. (1993). Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 90, 9649-9653.
70. Serby, M. (1986). Olfaction and Alzheimer's disease. Progressive Neuro-Psychopharmacol and Biological Psychiatry, 10, 579-586.
71. Serby, M., Larson, P., & Kalkstein, D. (1991). The nature and course of olfactory deficits in Alzheimer's disease. American Journal of Psychiatry, 148, 357-360.
72. Small, B. J., Basun, H., & Bäckman, L. (1998). Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia. Psychology and Aging, 13, 80-87.
73. Small, G. W., Komo, S., LaRue, A., Saxena, S., Phelps, M. E., Mazziotta, J. C. W. B., et al. (1996). Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Annals of the New York Academy of Sciences, 802, 70-78.
74. Soininen, H., Partanen, K., Pitkanen, A., Hallikainen, M., Hanninen, T., Helisalmi, S., et al. (1995). Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology, 45, 391-392.
75. Soininen, H. S., & Riekkinen, P. J., Sr. (1996). Apolipoprotein E, memory and Alzheimer's disease. Trends in Neuroscience, 19, 224-228.
76. Solomon, P. R., Brett, M., Groccia-Ellison, M. E., Oyler, C., Tomasi, M., & Pendlebury, W. W. (1995). Classical conditioning in patients with Alzheimer's disease: A multiday study. Psychology and Aging, 10, 248-254.
77. Solomon, P. R., & Gottfried, K. W. (1981). The septo-hippocampal cholinergic system and classical conditioning of the rabbit's nictitating membrane response. Journal of Comparative and Physiological Psychology, 95, 322-330.
78. Solomon, P. R., Groccia-Ellison, M., Levine, E., & Blanchard, S. (1990). Do temporal relationships in conditioning change across the life span? Perspectives from eyeblink conditioning in humans and rabbits. Annals of the New York Academy of Sciences, 608, 212-238.
79. Solomon, P. R., Levine, R., Bein, P., & Pendlebury, W. W. (1991). Classical eyeblink conditioning in Alzheimer's disease patients. Neurobiology of Aging, 12, 283-287.
80. Solomon, P. R., Pomerleau, D., Bennett, L., James, J., & Morse, D. L. (1989). Acquisition of the classically conditioned eyeblink response in humans over the life span. Psychology and Aging, 4, 34-41.
81. Solomon, P. R., Solomon, S. D., Schaaf, E. V., & Perry, H. E. (1983, April). Altered activity in the hippocampus is more detrimental to classical conditioning than removing the structure. Science, 220, 329-331.
82. Squire, L. R. (1987). Memory and brain. New York: Oxford University Press.
83. Steinmetz, J. E. (2000). Brain substrates of classical eyeblink conditioning: A highly localized but also distributed system. Behavioral Brain Research, 110, 13-24.
84. Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L.-M., Jakes, R., et al. (1994). Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 91, 11183-11186.
85. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993). Apolipoprotein E: High-avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 90, 1977-1981.
86. Syed, A. B., Armstrong, R. A., & Smith, C. U. M. (2000). Quantification of axonal loss in Alzheimer's disease: An image analysis study. Alzheimer's Reports, 3, 19-24.
87. Thompson, R. F. (1986). The neurobiology of learning and memory. Science, 233, 941-947.
88. Thompson, R. F. (1988). Commentary: Classical conditioning: The Rosetta Stone for brain substrates of age-related deficits in learning and memory? Neurobiology of Aging, 9, 547-548.
89. Thompson, R. F., & Krupa, D. J. (1994). Organization of memory traces in the mammalian brain. Annual Review of Neuroscience, 17, 519-549.
90. Wang, Q. S., Tian, L., Huang, Y. L., Qin, S., He, L. Q., & Zhou, J. N. (2002). Olfactory identification and apolipoprotein E epsilon 4 allele in mild cognitive impairment. Brain Research, 951, 77-81.
91. Warner, M. D., Peabody, C. A., Flattery, J. J., & Tinklenberg, J. R. (1986). Olfactory deficits and Alzheimer's disease. Biological Psychiatry, 21, 116-118.
92. Wenham, P. R., Price, W. H., & Blundell, G. (1991). Apolipoprotein E typing by one-stage PCR. Lancet, 337, 1158-1159.
93. Woodruff-Pak, D. S. (2001). Eyeblink classical conditioning differentiates normal aging from Alzheimer's disease. Integrative Physiological and Behavioral Science, 36, 87-108.
94. Woodruff-Pak, D. S., Finkbiner, R. G., & Sasse, D. K. (1990). Eyeblink conditioning discriminates Alzheimer's patients from non-demented aged. NeuroReport, 1, 45-49.
95. Woodruff-Pak, D. S., Jaeger, M. E., Gorman, C., & Wesnes, K. A. (1999). Relationships among age, conditioned stimulus-unconditioned stimulus interval, and neuropsychological test performance. Neuropsychology, 13, 90-102.
96. Woodruff-Pak, D. S., & Papka, M. (1996). Alzheimer's disease and eye-blink classical conditioning: 750 ms trace vs. 400 ms delay paradigm. Neurobiology of Aging, 17, 397-404.
97. Woodruff-Pak, D. S., Romano, S., & Papka, M. (1996). Training to criterion in eyeblink classical conditioning in Alzheimer's disease, Down's syndrome with Alzheimer's disease, and healthy elderly. Behavioral Neuroscience, 110, 22-29.
98. Woodruff-Pak, D. S., & Thompson, R. F. (1988). Classical conditioning in the delay paradigm in adults aged 18-83 years. Psychology and Aging, 3, 219-229.